Christopher N Scanlan

Author PubWeight™ 34.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 2003 6.68
2 A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 2011 5.44
3 Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc Natl Acad Sci U S A 2010 2.51
4 The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. PLoS One 2011 1.95
5 Emerging principles for the therapeutic exploitation of glycosylation. Science 2014 1.83
6 Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody. Angew Chem Int Ed Engl 2004 1.41
7 Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans. Glycobiology 2010 1.39
8 A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120. J Virol 2008 1.34
9 Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain. J Mol Biol 2013 1.26
10 Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity. J Mol Biol 2010 1.22
11 Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis. J Am Chem Soc 2012 1.12
12 A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity. Proc Natl Acad Sci U S A 2010 1.10
13 Antigenic mimicry of the HIV envelope by AIDS-associated pathogens. AIDS 2008 1.08
14 An endoglycosidase with alternative glycan specificity allows broadened glycoprotein remodelling. J Am Chem Soc 2012 1.03
15 Ion mobility mass spectrometry for extracting spectra of N-glycans directly from incubation mixtures following glycan release: application to glycans from engineered glycoforms of intact, folded HIV gp120. J Am Soc Mass Spectrom 2011 1.01
16 Engineering hydrophobic protein-carbohydrate interactions to fine-tune monoclonal antibodies. J Am Chem Soc 2013 0.96
17 Selective deactivation of serum IgG: a general strategy for the enhancement of monoclonal antibody receptor interactions. J Mol Biol 2012 0.96
18 Travelling wave ion mobility and negative ion fragmentation for the structural determination of N-linked glycans. Electrophoresis 2013 0.88
19 MALDI-MS/MS with traveling wave ion mobility for the structural analysis of N-linked glycans. J Am Soc Mass Spectrom 2012 0.85
20 Use of the α-mannosidase I inhibitor kifunensine allows the crystallization of apo CTLA-4 homodimer produced in long-term cultures of Chinese hamster ovary cells. Acta Crystallogr Sect F Struct Biol Cryst Commun 2011 0.76
21 Application of negative ion MS/MS to the identification of N-glycans released from carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1). J Mass Spectrom 2009 0.76